Literature DB >> 19368894

The crystal structure of cobra venom factor, a cofactor for C3- and C5-convertase CVFBb.

Vengadesan Krishnan1, Karthe Ponnuraj, Yuanyuan Xu, Kevin Macon, John E Volanakis, Sthanam V L Narayana.   

Abstract

Cobra venom factor (CVF) is a functional analog of human complement component C3b, the active fragment of C3. Similar to C3b, in human and mammalian serum, CVF binds factor B, which is then cleaved by factor D, giving rise to the CVFBb complex that targets the same scissile bond in C3 as the authentic complement convertases C4bC2a and C3bBb. Unlike the latter, CVFBb is a stable complex and an efficient C5 convertase. We solved the crystal structure of CVF, isolated from Naja naja kouthia venom, at 2.6 A resolution. The CVF crystal structure, an intermediate between C3b and C3c, lacks the TED domain and has the CUB domain in an identical position to that seen in C3b. The similarly positioned CUB and slightly displaced C345c domains of CVF could play a vital role in the formation of C3 convertases by providing important primary binding sites for factor B.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19368894      PMCID: PMC2671072          DOI: 10.1016/j.str.2009.01.015

Source DB:  PubMed          Journal:  Structure        ISSN: 0969-2126            Impact factor:   5.006


  63 in total

1.  Each of the three binding sites on complement factor H interacts with a distinct site on C3b.

Authors:  T S Jokiranta; J Hellwage; V Koistinen; P F Zipfel; S Meri
Journal:  J Biol Chem       Date:  2000-09-08       Impact factor: 5.157

2.  Identification of the C3b binding site in a recombinant vWF-A domain of complement factor B by surface-enhanced laser desorption-ionisation affinity mass spectrometry and homology modelling: implications for the activity of factor B.

Authors:  J Hinshelwood; D I Spencer; Y J Edwards; S J Perkins
Journal:  J Mol Biol       Date:  1999-11-26       Impact factor: 5.469

3.  Structure-guided identification of C3d residues essential for its binding to complement receptor 2 (CD21).

Authors:  L Clemenza; D E Isenman
Journal:  J Immunol       Date:  2000-10-01       Impact factor: 5.422

4.  Two clusters of acidic amino acids near the NH2 terminus of complement component C4 alpha'-chain are important for C2 binding.

Authors:  Q Pan; R O Ebanks; D E Isenman
Journal:  J Immunol       Date:  2000-09-01       Impact factor: 5.422

5.  Common binding region of complement factors B, H and CR1 on C3b revealed by monoclonal anti-C3d.

Authors:  V Koistinen; S Wessberg; J Leikola
Journal:  Complement Inflamm       Date:  1989

6.  The structure of bovine complement component 3 reveals the basis for thioester function.

Authors:  Folmer Fredslund; Lasse Jenner; Lise B Husted; Jens Nyborg; Gregers Rom Andersen; Lars Sottrup-Jensen
Journal:  J Mol Biol       Date:  2006-06-21       Impact factor: 5.469

7.  Structures of complement component C3 provide insights into the function and evolution of immunity.

Authors:  Bert J C Janssen; Eric G Huizinga; Hans C A Raaijmakers; Anja Roos; Mohamed R Daha; Kristina Nilsson-Ekdahl; Bo Nilsson; Piet Gros
Journal:  Nature       Date:  2005-09-22       Impact factor: 49.962

8.  Proteolytic activity of the different fragments of factor B on the third component of complement (C3). Involvement of the N-terminal domain of Bb in magnesium binding.

Authors:  P Sánchez-Corral; L C Antón; J M Alcolea; G Marqués; A Sánchez; F Vivanco
Journal:  Mol Immunol       Date:  1990-09       Impact factor: 4.407

9.  Inhibition of complement activation by recombinant Sh-CRIT-ed1 analogues.

Authors:  Kwang-Seok Oh; Mee-Hyang Kweon; Ki-Hyeong Rhee; Keyong Ho Lee; Ha-Chin Sung
Journal:  Immunology       Date:  2003-09       Impact factor: 7.397

10.  Complement and neutrophil-mediated injury of perfused rat lungs.

Authors:  M L Morganroth; G O Till; R G Kunkel; P A Ward
Journal:  Lab Invest       Date:  1986-05       Impact factor: 5.662

View more
  8 in total

1.  Substrate recognition by complement convertases revealed in the C5-cobra venom factor complex.

Authors:  Nick S Laursen; Kasper R Andersen; Ingke Braren; Edzard Spillner; Lars Sottrup-Jensen; Gregers R Andersen
Journal:  EMBO J       Date:  2011-01-07       Impact factor: 11.598

2.  Structure of Streptococcus agalactiae tip pilin GBS104: a model for GBS pili assembly and host interactions.

Authors:  Vengadesan Krishnan; Prabhat Dwivedi; Brandon J Kim; Alexandra Samal; Kevin Macon; Xin Ma; Arunima Mishra; Kelly S Doran; Hung Ton-That; Sthanam V L Narayana
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  2013-05-15

3.  Insights into complement convertase formation based on the structure of the factor B-cobra venom factor complex.

Authors:  Bert J C Janssen; Lucio Gomes; Roman I Koning; Dmitri I Svergun; Abraham J Koster; David C Fritzinger; Carl-Wilhelm Vogel; Piet Gros
Journal:  EMBO J       Date:  2009-07-02       Impact factor: 11.598

4.  Inhibition of the alternative complement pathway preserves photoreceptors after retinal injury.

Authors:  J Harry Sweigard; Hidetaka Matsumoto; Kaylee E Smith; Leo A Kim; Eleftherios I Paschalis; Yoko Okonuki; Alexandra Castillejos; Keiko Kataoka; Eiichi Hasegawa; Ryoji Yanai; Deeba Husain; John D Lambris; Demetrios Vavvas; Joan W Miller; Kip M Connor
Journal:  Sci Transl Med       Date:  2015-07-22       Impact factor: 17.956

Review 5.  Targeting complement components C3 and C5 for the retina: Key concepts and lingering questions.

Authors:  Benjamin J Kim; Dimitrios C Mastellos; Yafeng Li; Joshua L Dunaief; John D Lambris
Journal:  Prog Retin Eye Res       Date:  2020-12-13       Impact factor: 19.704

6.  Human Neutrophils Respond to Complement Activation and Inhibition in Microfluidic Devices.

Authors:  Sinan Muldur; Douangsone D Vadysirisack; Sharan Ragunathan; Yalan Tang; Alonso Ricardo; Camil Elie Sayegh; Daniel Irimia
Journal:  Front Immunol       Date:  2021-11-24       Impact factor: 7.561

Review 7.  Putting the structure into complement.

Authors:  Susan M Lea; Steven Johnson
Journal:  Immunobiology       Date:  2012-11       Impact factor: 3.144

8.  Complement depletion with cobra venom factor alleviates acute hepatic injury induced by ischemia‑reperfusion.

Authors:  Bing Wang; Hua Xu; Jian Li; Hong-Mei Gao; Ying-Hong Xing; Zhu Lin; Hong-Jie Li; Yong-Qiang Wang; Shu-Hua Cao
Journal:  Mol Med Rep       Date:  2018-09-14       Impact factor: 2.952

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.